LHX3 promotes EMT in hepatoma cell through β-catenin/TCF4 pathway

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33.

Article  PubMed  Google Scholar 

Koshy A. Evolving global etiology of hepatocellular carcinoma (HCC): insights and trends for 2024. J Clin Exp Hepatol. 2025;15:102406.

Article  CAS  PubMed  Google Scholar 

Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev. 2023;42:629–52.

Article  PubMed  Google Scholar 

Couri T, Pillai A. Goals and targets for personalized therapy for HCC. Hepatol Int. 2019;13:125–37.

Article  PubMed  Google Scholar 

Brabletz S, Schuhwerk H, Brabletz T, Stemmler MP. Dynamic EMT: a multi-tool for tumor progression. EMBO J. 2021;40:e108647.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29:212–26.

Article  CAS  PubMed  Google Scholar 

Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15:129.

Article  PubMed  PubMed Central  Google Scholar 

Singh M, Yelle N, Venugopal C, Singh SKEMT. Mechanisms and therapeutic implications. Pharmacol Ther. 2018;182:80–94.

Article  CAS  PubMed  Google Scholar 

Chen T, You Y, Jiang H, Wang ZZ. Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis. J Cell Physiol. 2017;232:3261–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, et al. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm Sin B. 2022;12:558–80.

Article  CAS  PubMed  Google Scholar 

Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022;21:144.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Teeuwssen M, Fodde R. Wnt signaling in ovarian cancer stemness, EMT, and therapy resistance. J Clin Med. 2019;8:1658.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal. 2014;7:re8.

Article  PubMed  PubMed Central  Google Scholar 

Singh N, Singh D, Modi D. LIM homeodomain (LIM-HD) genes and their co-regulators in developing reproductive system and disorders of sex development. Sex Dev. 2022;16:147–61.

Article  CAS  PubMed  Google Scholar 

Winchell CJ, Jacobs DK. Expression of the Lhx genes apterous and lim1 in an errant polychaete: implications for bilaterian appendage evolution, neural development, and muscle diversification. EvoDevo. 2013;4:4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forouzesh F, Ghiaghi M, Rahimi H. Effect of sodium butyrate on HDAC8 mRNA expression in colorectal cancer cell lines and molecular docking study of LHX1—sodium butyrate interaction. EXCLI J. 2020;19:1038–51.

PubMed  PubMed Central  Google Scholar 

Zhang Z, Gu M, He G, Yu X, Yang J, Wu X, et al. LHX2 is a potential biomarker and associated with immune infiltration in breast cancer. Cancers. 2023;15:2773.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin X, Li Y, Wang J, Han F, Lu S, Wang Y, et al. LHX3 is an early stage and radiosensitivity prognostic biomarker in lung adenocarcinoma. Oncol Rep. 2017;38:1482–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hung TM, Hu RH, Ho CM, Chiu YL, Lee JL, Jeng YM, et al. Downregulation of alpha-fetoprotein expression by LHX4: a critical role in hepatocarcinogenesis. Carcinogenesis. 2011;32:1815–23.

Article  CAS  PubMed  Google Scholar 

Wu Y, Peng X, Ang S, Gao Y, Chi Y, Wang J, et al. Bcl-xL promotes the survival of motor neurons derived from neural stem cells. Biology. 2023;12:132.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dietrich D, Lesche R, Tetzner R, Krispin M, Dietrich J, Haedicke W, et al. Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues. J Histochem Cytochem. 2009;57:477–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu H, Liu W, Zhu B, Xu Q, Ni X, Yu J. Lhx3 is required to maintain cancer cell development of high-grade oligodendroglioma. Mol Cell Biochem. 2015;399:1–5.

Article  CAS  PubMed  Google Scholar 

Huang B, Tian ZF, Li LF, Fan Y, Yin HY, Li Y, et al. LHX3 is an advanced-stage prognostic biomarker and metastatic oncogene in hepatocellular carcinoma. Cancer Biomark. 2019;26:31–9.

Article  CAS  PubMed  Google Scholar 

Rim EY, Clevers H, Nusse R. The Wnt pathway: from signaling mechanisms to synthetic modulators. Annu Rev Biochem. 2022;91:571–98.

Article  CAS  PubMed  Google Scholar 

He S, Tang S. WNT/β-catenin signaling in the development of liver cancers. Biomed Pharmacother. 2020;132:110851.

Article  CAS  PubMed  Google Scholar 

Yu F, Yu C, Li F, Zuo Y, Wang Y, Yao L, et al. Wnt/β-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther. 2021;6:307.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xia S, Pan Y, Liang Y, Xu J, Cai X. The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma. EBioMedicine. 2020;51:102610.

Article  PubMed  PubMed Central  Google Scholar 

Wang Z, Li Z, Ji H. Direct targeting of β-catenin in the Wnt signaling pathway: current progress and perspectives. Med Res Rev. 2021;41:2109–29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Wang X. Targeting the Wnt/β-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13:165.

Article  PubMed  PubMed Central  Google Scholar 

Antony L, van der Schoor F, Dalrymple SL, Isaacs JT. Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription. Prostate. 2014;74:1118–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi G, Lee J, Ji JY, Woo J, Kang NS, Cho SY, et al. Discovery of a potent small molecule SIRT1/2 inhibitor with anticancer effects. Int J Oncol. 2013;43:1205–11.

Article 

留言 (0)

沒有登入
gif